antigen loss reduces the efficacy of CAR-T cell therapy, limiting long-term treatment success. While such mechanisms are undertaken by the tumor cells of a patient, a particular CAR-T cell treatment whose antigen has been the subject of tumor evasion can no longer be utilized for the treatment...